ERBB2 and gastric cancer: The overexpression of human epidermal growth factor receptor 2 (ERBB2) promotes the differentiation and proliferation of cancer cells, which is recognized as one of the key causes of GC and seriously affects the prognosis of GC patients [52, 53].